The major problems relating to insulin therapy are the therapeutic burden for the pregnant woman (discomfort, fear of injections, and cost), the risk of hypoglycemia, and the increased health care resources required for insulin initiation and stabilization. This evidence concerns the gene INS and Hypoglycemia.